Studies have shown that active fund managers routinely underperform the S&P500 index*​

LeMaitre Vascular, Inc. (NASDAQ: LMAT)

LMAT Stock Predictions and Ratings

WSX Rating:
HOLD
WSX Forecast (1yr):
2.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-38.60%

LMAT Stock Analysis

LMAT PE Ratio: 33.8

LMAT PEG Ratio: 4

LMAT Forward EPS Growth (12 month): 8.40%

LMAT PS Ratio: 8.2

LMAT PSG Ratio: 0.9

LMAT Forward Revenue Growth (12 month): 8.90%

LMAT Articles

No data was found